Date:10/4/2011

ucer System Market Leaders, U.S., 2009 135
DETACHABLE COIL MARKET. 136
Chart 7-1: Total Detachable Coil Market, U.S., 2006 – 2016 .. 139
Chart 7-2: Units Sold in the Detachable Coil Market, U.S., 2006 – 2016 . 140
Chart 7-3: Detachable Coil Market Value by Type, U.S., 2006 – 2016 142
Chart 7-4: Detachable Coil Units Sold by Type, U.S., 2006 – 2016 .. 144
Chart 7-5: Bare Platinum Coil Market, U.S., 2006 – 2016 .. 146
Chart 7-6: Units Sold in the Bare Platinum Coil Market, U.S., 2006 – 2016.. 147
Chart 7-7: Coated Coil Market, U.S., 2006 – 2016 . 149
Chart 7-8: Units Sold in the Coated Coil Market, U.S., 2006 – 2016. 150
Chart 7-9: Leading Competitors in the Detachable Coils Market, U.S., 2009 154
LIQUID EMBOLICS.. 155
Chart 8-1: Liquid Embolics Market, U.S., 2006 – 2016 . 158
Chart 8-2: Units Sold in the Liquid Embolics Market, U.S., 2006 – 2016. 159
Chart 8-3: Leading Competitors in the Liquid Embolics Market, U.S., 2009 . 162
NEUROVASCULAR STENT MARKET .... 163
Chart 9-1: Neurovascular Stent Market, U.S., 2006 – 2016 168
Chart 9-2: Units Sold in the Neurovascular Stent Market, U.S., 2006 – 2016 .... 169
Chart 9-3: Leading Competitors in the Neurovascular Stent Market, U.S., 2009 173
NEUROVASCULAR CATHETER MARKET ... 175
Chart 10-1: Total Neurovascular Catheter Market, U.S., 2006 – 2016 . 177
Chart 10-2: Units Sold in the Total Neurovascular Catheter Market, U.S., 2006 –
2016 . 178
Chart 10-3: Over-the-wire Microcatheter Market, U.S., 2006 – 2016 180
Chart 10-4: Over-the-wire Microcatheter Market, U.S., 2006 – 2016 181
Chart 10-5: Flow-directed Microcatheter Market, U.S., 2006 – 2016 183
Chart 10-6: Units Sold in Flow-directed Microcatheter Market, U.S., 2006 –
2016 . 184
Chart 10-7: Guiding Catheter Market, U.S., 2006 – 2016 ... 186
Chart
'/>"/>

SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine technology :

1. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
5. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
9. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
11. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)